In fact, there were some reports suggesting that inhibition of HDACs using various known HDAC inhibitors exhibited antitumor activities and/or apoptotic effects in HCC model systems including HCC-derived cell lines or murine models [11], [12]. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.